Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac

Nduna Dzimiri1, Paul Muiya, Editha Andres

  • 1Cardiovascular Pharmacology Unit, Biological and Medical Research Department, King Faisal Specialist Hospital and Research Centre, PO Box 3354, Riyadh 11211, Saudi Arabia. dzimiri@kfshrc.edu.sa

Insights

G protein-coupled receptor kinases (GRKs) expression differs in heart disease. GRK2 and GRK5 levels increase in dilated cardiomyopathy and volume overload, impacting beta-adrenoceptor signaling.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Myocardial G protein-coupled receptor kinase (GRK) expression and beta-adrenoceptor signaling are crucial in human heart diseases.
  • Previous research has not fully elucidated the specific roles of GRKs in left heart diseases.

Purpose of the Study:

  • To characterize and compare GRK2-7 expression in patients with left ventricular volume overload and dilated cardiomyopathy.
  • To evaluate the relationship between GRK expression and altered myocardial beta-adrenoceptor signaling.
  • To determine if GRK functional expression is influenced in a disease-specific manner.

Main Methods:

  • Quantitative analysis of GRK2-7 mRNA and protein expression in human heart tissue samples.
  • Comparison of GRK expression levels between healthy controls, dilated cardiomyopathy, and volume overload groups.
  • Assessment of myocardial beta-adrenoceptor signaling, adenylyl cyclase activity, and protein kinase A activity.

Main Results:

  • GRK2, GRK3, and GRK5 are expressed in healthy human hearts; GRK4, GRK6, and GRK7 are scarce.
  • GRK2 mRNA significantly increased in all chambers in dilated cardiomyopathy and volume overload.
  • GRK5 elevated in the left ventricle in both conditions; GRK3 showed minor changes.

Conclusions:

  • GRK expression is regulated differently in various cardiac diseases.
  • Increased GRK2 expression correlates with global changes in myocardial adrenoceptor function.
  • GRK5 alterations may be localized to ventricles, depending on the specific cardiac load.